GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ablynx NV (XBRU:ABLXS) » Definitions » Net Margin %

Ablynx NV (XBRU:ABLXS) Net Margin % : -398.18% (As of Dec. 2017)


View and export this data going back to . Start your Free Trial

What is Ablynx NV Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Ablynx NV's Net Income for the six months ended in Dec. 2017 was €-83.21 Mil. Ablynx NV's Revenue for the six months ended in Dec. 2017 was €20.90 Mil. Therefore, Ablynx NV's net margin for the quarter that ended in Dec. 2017 was -398.18%.

The historical rank and industry rank for Ablynx NV's Net Margin % or its related term are showing as below:

XBRU:ABLXS' s Net Margin % Range Over the Past 10 Years
Min: -221.01   Med: -74.46   Max: -1.28
Current: -195.33


XBRU:ABLXS's Net Margin % is not ranked
in the Biotechnology industry.
Industry Median: -154.37 vs XBRU:ABLXS: -195.33

Ablynx NV Net Margin % Historical Data

The historical data trend for Ablynx NV's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ablynx NV Net Margin % Chart

Ablynx NV Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -58.68 -26.68 -71.06 -1.28 -195.33

Ablynx NV Semi-Annual Data
Dec07 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -101.58 42.98 -75.54 -73.05 -398.18

Competitive Comparison of Ablynx NV's Net Margin %

For the Biotechnology subindustry, Ablynx NV's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ablynx NV's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ablynx NV's Net Margin % distribution charts can be found below:

* The bar in red indicates where Ablynx NV's Net Margin % falls into.



Ablynx NV Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Ablynx NV's Net Margin for the fiscal year that ended in Dec. 2017 is calculated as

Net Margin=Net Income (A: Dec. 2017 )/Revenue (A: Dec. 2017 )
=-108.532/55.562
=-195.33 %

Ablynx NV's Net Margin for the quarter that ended in Dec. 2017 is calculated as

Net Margin=Net Income (Q: Dec. 2017 )/Revenue (Q: Dec. 2017 )
=-83.208/20.897
=-398.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ablynx NV  (XBRU:ABLXS) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Ablynx NV Net Margin % Related Terms

Thank you for viewing the detailed overview of Ablynx NV's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ablynx NV (XBRU:ABLXS) Business Description

Traded in Other Exchanges
N/A
Address
Ablynx NV is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. It has 45 proprietary and partnered programs in development in various therapeutic areas including inflammation, hematology, immuno-oncology, oncology and respiratory disease. It has collaborations with multiple pharmaceutical companies including AbbVie; Boehringer Ingelheim; Eddingpharm; Merck & Co., Inc., Kenilworth, New Jersey, USA; Merck KGaA; Novartis; Novo Nordisk; Sanofi and Taisho Pharmaceuticals. The company generates revenue from research collaboration agreements and from government grants.

Ablynx NV (XBRU:ABLXS) Headlines

No Headlines